407 related articles for article (PubMed ID: 18505832)
1. The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans.
Rigazio S; Lehto HR; Tuunanen H; Någren K; Kankaanpaa M; Simi C; Borra R; Naum AG; Parkkola R; Knuuti J; Nuutila P; Iozzo P
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E413-9. PubMed ID: 18505832
[TBL] [Abstract][Full Text] [Related]
2. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
[TBL] [Abstract][Full Text] [Related]
3. Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production.
Carey PE; Gerrard J; Cline GW; Dalla Man C; English PT; Firbank MJ; Cobelli C; Taylor R
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E941-7. PubMed ID: 15998660
[TBL] [Abstract][Full Text] [Related]
4. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
5. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.
Lam TK; Yoshii H; Haber CA; Bogdanovic E; Lam L; Fantus IG; Giacca A
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E682-91. PubMed ID: 12217885
[TBL] [Abstract][Full Text] [Related]
6. Effects of free fatty acids on carbohydrate metabolism and insulin signalling in perfused rat liver.
Anderwald C; Brunmair B; Stadlbauer K; Krebs M; Fürnsinn C; Roden M
Eur J Clin Invest; 2007 Oct; 37(10):774-82. PubMed ID: 17888088
[TBL] [Abstract][Full Text] [Related]
7. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
Lam TK; van de Werve G; Giacca A
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E281-90. PubMed ID: 12531742
[TBL] [Abstract][Full Text] [Related]
8. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
Rijzewijk LJ; Jonker JT; van der Meer RW; Lubberink M; de Jong HW; Romijn JA; Bax JJ; de Roos A; Heine RJ; Twisk JW; Windhorst AD; Lammertsma AA; Smit JW; Diamant M; Lamb HJ
J Am Coll Cardiol; 2010 Jul; 56(3):225-33. PubMed ID: 20620743
[TBL] [Abstract][Full Text] [Related]
9. Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid.
Dhalla AK; Santikul M; Smith M; Wong MY; Shryock JC; Belardinelli L
J Pharmacol Exp Ther; 2007 Apr; 321(1):327-33. PubMed ID: 17204748
[TBL] [Abstract][Full Text] [Related]
10. A1 adenosine receptor partial agonist lowers plasma FFA and improves insulin resistance induced by high-fat diet in rodents.
Dhalla AK; Wong MY; Voshol PJ; Belardinelli L; Reaven GM
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1358-63. PubMed ID: 17227958
[TBL] [Abstract][Full Text] [Related]
11. Accretion of visceral fat and hepatic insulin resistance in pregnant rats.
Einstein FH; Fishman S; Muzumdar RH; Yang XM; Atzmon G; Barzilai N
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E451-5. PubMed ID: 18073320
[TBL] [Abstract][Full Text] [Related]
12. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
Zheng LY; Pan JQ; Lv JH
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics.
Krag MB; Gormsen LC; Guo Z; Christiansen JS; Jensen MD; Nielsen S; Jørgensen JO
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E920-7. PubMed ID: 17132823
[TBL] [Abstract][Full Text] [Related]
14. Effects of acute and one-week fatty acid lowering on cardiac function and insulin sensitivity in relation with myocardial and muscle fat and adiponectin levels.
Lehto HR; Pärkkä J; Borra R; Tuunanen H; Lepomaki V; Parkkola R; Knuuti J; Nuutila P; Iozzo P
J Clin Endocrinol Metab; 2012 Sep; 97(9):3277-84. PubMed ID: 22761459
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lipolysis does not affect insulin sensitivity to glucose uptake in the mourning dove.
Sweazea KL; McMurtry JP; Braun EJ
Comp Biochem Physiol B Biochem Mol Biol; 2006 Jul; 144(3):387-94. PubMed ID: 16753324
[TBL] [Abstract][Full Text] [Related]
16. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.
Park E; Wong V; Guan X; Oprescu AI; Giacca A
J Endocrinol; 2007 Nov; 195(2):323-31. PubMed ID: 17951543
[TBL] [Abstract][Full Text] [Related]
17. [Macronutrients, fat mass, fatty acid flux and insulin sensitivity].
Ziegler O; Quilliot D; Guerci B; Drouin P
Diabetes Metab; 2001 Apr; 27(2 Pt 2):261-70. PubMed ID: 11452220
[TBL] [Abstract][Full Text] [Related]
18. Short-term suppression of plasma free fatty acids fails to improve insulin sensitivity when intramyocellular lipid is elevated.
Johnson NA; Stannard SR; Rowlands DS; Chapman PG; Thompson CH; Sachinwalla T; Thompson MW
Diabet Med; 2006 Oct; 23(10):1061-8. PubMed ID: 16978369
[TBL] [Abstract][Full Text] [Related]
19. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
20. Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.
Gastaldelli A; Casolaro A; Ciociaro D; Frascerra S; Nannipieri M; Buzzigoli E; Ferrannini E
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E225-30. PubMed ID: 19417125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
